GSK Investigational Site

Phoenix, Arizona 85012

Use our guide to learn which trials are right for you!

We've found
6 trials
at this facility
Systemic Lupus Erythematosus Clinical Trial
Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Phoenix, AZ
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Cholestasis Clinical Trial
Dose Response Study of GSK2330672 for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Phoenix, AZ
Click here to add this to my saved trials
HIV INfections Clinical Trial
Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)- Positive Subjects From the LATTE Study
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Phoenix, AZ
Click here to add this to my saved trials